Home Latest Stories Vaccine Panel Chief On Pfizer, Moderna Offers

Vaccine Panel Chief On Pfizer, Moderna Offers


'Not Even Enough For...': Vaccine Panel Chief On Pfizer, Moderna Offers

Mr Arora said the amount of drugs these US-based vaccine makers are offering is not large.

All US-based vaccine makers are insisting on indemnity and liability clauses and India’s reluctance to meet them is slowing down their entry in the market, NK Arora, head of the government’s vaccine panel told NDTV yesterday. He, however, revealed that the country’s plan to vaccinate all eligible adults by December does not depend on foreign vaccines.

Dr Arora, however, indicated that the government would have reconsidered its stance on indemnity if the vaccine makers were willing to provide a larger amount of vaccines — like 100 or 200 million doses.

Pfizer, he said, has offered only 70 million doses — a tiny fraction of the 135 crore doses India needs by December. Moderna, he said, offered only 7.5 million doses, “which will be insufficient even for Saket (in south Delhi)”.

Earlier today, it became known that Johnson & Johnson pulled out its proposal seeking an accelerated approval for local trials, though the firm said it is still in talks with the Indian government, “exploring how best to accelerate our ability to deliver our COVID-19 vaccine to India”.

 “The overall issue is that for the US vaccine manufacturers Pfizer, Moderna, J&J — one of the requirements they have kept is what they call the paperwork and it is indemnity and liability related clauses which has to be met by the recipient country,” said Mr Arora, describing the indemnity clause as a “major hurdle”.

This would mean that in case of any vaccine-related adverse event, the vaccine maker cannot be sued — condition the government is no keen to meet.

India has been having discussions with the firms. With Pfizer, despite talks since January, the paperwork has not been submitted. Johnson and Johnson submitted the papers and then withdrew then, he added.

Mr Arora also said the amount of drugs these US-based vaccine makers are offering is not large, citing the case of the Pfizer vaccine.

It is because of this, and the indemnity clause, the foreign vaccines have not been factored in while drawing up the supply plans for the December deadline.

India, he said, needs to look at its own “industry’s well-being” as the biggest vaccine manufacturer. “2022 onwards, India can be a major vaccine supplier to the rest of the world,” he added.



Source link

RELATED ARTICLES

Delhi-Mumbai Expressway To Earn Rs 1,000 Crore Revenue Per Month: Nitin Gadkari

<!-- -->Nitin Gadkari said the national highways infrastructure is a world-class success story. (File)New Delhi: The Centre will get toll revenues worth Rs...

Senior Leader Ambika Soni Refuses To Succeed Amarinder Singh, Say Sources

<!-- -->New Delhi: Senior Congress leader Ambika Soni was asked to succeed Amarinder Singh as Punjab chief minister during a late-night meeting with...

PM Modi Urges People To Take Part In Auction Of Gifts Received By Him

<!-- -->PM Modi said the proceeds from the auction would go to the "Namami Gange" initiative. (File)New Delhi: Prime Minister Narendra Modi on...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Easy-to-make healthy sandwich recipes for your little one

When it comes to planning meals for kids, packing in the right nutritional punch keeping in mind the taste and visual appeal of...

Rahul Gandhi Says Event Over On Vaccine Record On PM Modi’s Birthday

<!-- -->Rahul Gandhi, using the hashtag 'vaccination', said in a tweet, "Event over". (File)New Delhi: Congress leader Rahul Gandhi on Sunday took a...

Kapil Sibal On Parties Changing Chief Ministers

<!-- -->Kapil Sibal asked if the change of guard wil be useful to parties (File)New Delhi: Pointing to the sudden change of guard...

How to Add Links to Your Instagram Stories

Instagram is a popular social platform for sharing links about work or some articles and stories worth mentioning. Influencers and creators also often...

Recent Comments